Previous close | 9.30 |
Open | 9.30 |
Bid | 6.60 |
Ask | 6.90 |
Strike | 140.00 |
Expiry date | 2024-11-15 |
Day's range | 9.30 - 9.30 |
Contract range | N/A |
Volume | |
Open interest | 24 |
Strength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels and reduced COVID-19 testing revenues pose concerns.
In Physician Lab Services, Quest Diagnostics (DGX) is benefiting from the broad-based return to care, overall market growth and share gains driven by the competitive strength of its scale and innovative offerings.
Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2024 financial results on Tuesday, July 23, 2024, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.